Vergoeding 2019-2023 voor ATC-subgroep L01FE : Egfr-remmers
- Raming voor de totale Zvw-populatie
| 2019 | 2020 | 2021* | 2022* | 2023* | |
|---|---|---|---|---|---|
| L01FE01 Cetuximab | 2.779.645 | 2.439.007 | 3.879.552 | 3.738.054 | 3.376.206 |
| L01FE02 Panitumumab | 7.737.450 | 7.670.491 | 7.150.829 | 7.161.431 | 6.561.623 |
| Totaal | 10.517.095 | 10.109.498 | 11.030.382 | 10.899.484 | 9.937.829 |